Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adverse Events with Normal Saline Nasal Irrigation vs Oxymetazoline plus Normal Saline Irrigation
TCTR20250128001Phase 3Unknown
- Sponsor
- -
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxymetazoline in nasal congestion (2 arms). Status: unknown.
02
Drugs
oxymetazoline
03
Conditions
nasal congestion
Beyond the preview
Go deeper on TCTR20250128001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250128001.